×
返回 Agenda
S10 : Impact of ICH E6 (R3) on GCP Inspection: from Global Perspectives
Session Chair(s)
Junko Sato, PhD
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Kotaro Fukuda
, Pharmaceuticals and Medical Devices Agency, Japan
Mitsuaki Aoyagi
, Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Yoshiaki Ohyama
Director, Professor, Innovative Medical Reserch Center, Gunma University Hospital, Japan
Yuka Kubota
Innovative Medical Research Center, Gunma University Hospital, Japan